The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

被引:2047
|
作者
Choe, H
Farzan, M
Sun, Y
Sullivan, N
Rollins, B
Ponath, PD
Wu, LJ
Mackay, CR
LaRosa, G
Newman, W
Gerard, N
Gerard, C
Sodroski, J
机构
[1] HARVARD UNIV,SCH PUBL HLTH,DEPT CANC BIOL,BOSTON,MA 02115
[2] LEUKOSITE INC,CAMBRIDGE,MA 02142
[3] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DEPT MED,BOSTON,MA 02115
[4] HARVARD UNIV,BETH ISRAEL HOSP,SCH MED,PERLMUTTER LAB,DEPT PEDIAT,DEPT MED,CHILDRENS HOSP,BOSTON,MA 02115
关键词
D O I
10.1016/S0092-8674(00)81313-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We examined the ability of chemokine receptors and related G protein-coupled receptors to facilitate infection by primary, clinical HIV-1 isolates. CCR5, when expressed along with CD4, the HIV-1 receptor, allowed cell lines resistant to most primary HIV-1 isolates to be infected. CCR3 facilitated infection by a more restricted subset of primary viruses, and binding of the CCR3 ligand, eotaxin, inhibited infection by these isolates. Utilization of CCR3 and CCR5 on the target cell depended upon the sequence of the third variable (V3) region of the HIV-1 gp120 exterior envelope glycoprotein. The ability of various members of the chemokine receptor family to support the early stages of HIV-1 infection helps to explain viral tropism and beta-chemokine inhibition of primary HIV-1 isolates.
引用
收藏
页码:1135 / 1148
页数:14
相关论文
共 50 条
  • [1] CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia
    Jianglin He
    Youzhi Chen
    Michael Farzan
    Hyeryun Choe
    Asa Ohagen
    Suzanne Gartner
    Jorge Busciglio
    Xiaoyu Yang
    Wolfgang Hofmann
    Walter Newman
    Charles R. Mackay
    Joseph Sodroski
    Dana Gabuzda
    [J]. Nature, 1997, 385 : 645 - 649
  • [2] CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia
    He, JL
    Chen, YZ
    Farzan, M
    Choe, HY
    Ohagen, A
    Gartner, S
    Busciglio, J
    Yang, XY
    Hofmann, W
    Newman, W
    Mackay, CR
    Sodroski, J
    Gabuzda, D
    [J]. NATURE, 1997, 385 (6617) : 645 - 649
  • [3] Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity
    Rucker, J
    Samson, M
    Doranz, BJ
    Libert, F
    Berson, JF
    Yi, YJ
    Smyth, RJ
    Collman, RG
    Broder, CC
    Vassart, G
    Doms, RW
    Parmentier, M
    [J]. CELL, 1996, 87 (03) : 437 - 446
  • [4] Role of the β-chemokine receptors CCR3 and CCR5 in human immunodeficiency virus type 1 infection of monocytes and microglia
    Ghorpade, A
    Xia, MQ
    Hyman, BT
    Persidsky, Y
    Nukuna, A
    Bock, P
    Che, MH
    Limoges, J
    Gendelman, HE
    Mackay, CR
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (04) : 3351 - 3361
  • [5] Expression of chemokine receptor CCR5 and CCR3 in Type 1 diabetes mellitus
    Liu, Y
    Chen, J
    Liu, C
    [J]. DIABETOLOGIA, 2002, 45 : A119 - A119
  • [6] Antagonist of chemokine receptors CCR1 and CCR3
    Alaina Ammit
    [J]. Respiratory Research, 2 (1)
  • [7] Distinct but overlapping epitopes for the interaction of a CC-chemokine with CCR1, CCR3, and CCR5
    Pakianathan, DR
    Kuta, EG
    Artis, DR
    Skelton, NJ
    Hebert, CA
    [J]. BIOCHEMISTRY, 1997, 36 (32) : 9642 - 9648
  • [8] Expression of the β-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue
    Simpson, J
    Rezaie, P
    Newcombe, J
    Cuzner, ML
    Male, D
    Woodroofe, MN
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2000, 108 (1-2) : 192 - 200
  • [9] Chemokine receptors CCR1, CCR3, CCR5 and CXCR3 expression in synovial T cells of patients with JIA.
    Massa, M
    Passalia, M
    Travaglino, P
    Pignatti, P
    Meazza, C
    Martini, A
    De Benedetti, F
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S338 - S338
  • [10] Immunohistochemical study of the β-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer's disease brains
    Xia, MQ
    Qin, SX
    Wu, LJ
    Mackay, CR
    Hyman, BT
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (01): : 31 - 37